Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece
Nikolopoulos, G K; Katsoulidou, A; Kantzanou, M; Rokka, C; Tsiara, C; Sypsa, V; Paraskevis, D; Psichogiou, M; Friedman, S; Hatzakis, A
This analysis assessed the utility of the limiting antigen avidity assay (LAg). Samples of people who inject drugs (PWID) in Greece with documented duration of HIV-1 infection were tested by LAg. A LAg-normalized optical density (ODn) ⩽1·5 corresponds to a recency window period of 130 days. The proportion true recent (PTR) and proportion false recent (PFR) were estimated in 28 seroconverters and in 366 samples collected >6 months after HIV diagnosis, respectively. The association between LAg ODn and HIV RNA level was evaluated in 232 persons. The PTR was 85·7%. The PFR was 20·8% but fell to 5·9% in samples from treatment-naive individuals with long-standing infection (>1 year), and to 0 in samples with the circulating recombinant form CRF35 AD. A LAg-based algorithm with a PFR of 3·3% estimated a similar incidence trend to that calculated by analyses based on HIV-1 seroconversions. In recently infected persons indicated by LAg, the median log10 HIV RNA level was high (5·30, interquartile range 4·56-5·90). LAg can help identify highly infectious HIV(+) individuals as it accurately identifies recent infections and is correlated with the HIV RNA level. It can also produce reliable estimates of HIV-1 incidence.
PMCID:6824880
PMID: 27780490
ISSN: 1469-4409
CID: 4842252
Network dynamics of HIV risk and prevention in a population-based cohort of young Black men who have sex with men
Schneider, J.; Cornwell, B.; Jonas, A.; Lancki, N.; Behler, R.; Skaathun, B.; Young, L. E.; Morgan, E.; Michaels, S.; Duvoisin, R.; Khanna, A. S.; Friedman, S.; Schumm, P.; Laumann, E.
ISI:000408564600007
ISSN: 2050-1242
CID: 4842162